PVLA
Palvella Therapeutics, Inc.Company with tickers: PVLA
CIK
1583648
CUSIP
697947109
Shares Outstanding
14,342,844
13F Activity (30d)
144 filings
142 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-08 | — | |
| 8-K | 2020-01-14 | 2020-01-13 | |
| 8-K | 2020-01-17 | — | |
| 8-K | 2020-01-24 | 2020-01-20 | |
| 8-K | 2020-02-28 | — | |
| 8-K | 2020-03-12 | — | |
| 10-K | 2020-03-13 | 2019-12-31 | |
| 8-K | 2020-03-24 | 2020-03-23 | |
| 8-K | 2020-04-06 | 2020-03-31 | |
| 8-K | 2020-05-11 | 2020-05-07 | |
| 10-Q | 2020-05-11 | 2020-03-31 | |
| 8-K | 2020-05-21 | — | |
| 8-K | 2020-06-04 | — | |
| 8-K | 2020-06-08 | — | |
| 8-K | 2020-06-29 | 2020-06-23 | |
| 8-K | 2020-07-20 | — | |
| 10-Q | 2020-08-10 | 2020-06-30 | |
| 8-K | 2020-08-10 | — | |
| 8-K | 2020-09-09 | — | |
| 8-K | 2020-09-21 | — | |
| 8-K | 2020-09-21 | 2020-09-19 | |
| 10-Q | 2020-11-04 | 2020-09-30 | |
| 8-K | 2020-11-04 | — | |
| 8-K | 2020-12-15 | — | |
| 8-K | 2021-03-25 | 2021-03-24 | |
| 8-K | 2021-03-30 | 2021-03-29 | |
| 8-K | 2021-03-30 | — | |
| 10-K | 2021-03-31 | 2020-12-31 | |
| 8-K | 2021-04-12 | 2021-04-10 | |
| 8-K | 2021-04-26 | 2021-04-24 | |
| 8-K | 2021-05-17 | — | |
| 10-Q | 2021-05-17 | 2021-03-31 | |
| 8-K | 2021-05-21 | 2021-05-20 | |
| 8-K | 2021-05-25 | 2021-05-19 | |
| 8-K | 2021-05-25 | — | |
| 8-K | 2021-06-25 | — | |
| 8-K | 2021-06-29 | 2021-06-25 | |
| 8-K | 2021-08-04 | — | |
| 10-Q | 2021-08-05 | 2021-06-30 | |
| 8-K | 2021-08-24 | — | |
| 8-K | 2021-08-30 | 2021-08-27 | |
| 8-K | 2021-10-06 | — | |
| 8-K | 2021-11-02 | — | |
| 10-Q | 2021-11-02 | 2021-09-30 | |
| 8-K | 2021-11-18 | — | |
| 8-K | 2022-01-03 | — | |
| 8-K/A | 2022-01-14 | 2021-11-18 | |
| 8-K | 2022-01-14 | — | |
| 8-K | 2022-01-24 | — | |
| 8-K | 2022-03-01 | — |
Showing 1–50 of 123 filings